Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.
Horn
D L
DL
Lincoln Medical and Mental Health Center, Bronx, New York.
Hewlett
D
D
Haas
W H
WH
Butler
W R
WR
Alfalla
C
C
Tan
E
E
Levine
A
A
Nayak
A
A
Opal
S M
SM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000382:microbiology; D000328:Adult; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D015163:Superinfection / Q000188:drug therapy* / Q000382:microbiology; D014390:Tuberculosis, Meningeal / Q000188:drug therapy* / Q000382:microbiology; D018088:Tuberculosis, Multidrug-Resistant / Q000382:microbiology*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin